Novel Deiodinase 2-Selective Inhibitors-Possible Reference Substances for Regulatory In Vitro Tests for Endocrine Disruptors and Drugs Targeting T3-Dependent Processes.

Imbruvica (ibrutinib) - AbbVie, J&J

Tiorfan (racecadotril) - Bioprojet

Xegafri (rociletinib) - Clovis

http://www.ncbi.nlm.nih.gov/pubmed/41822949

Anja Fischbach; Carola Seyffarth; Caroline Frädrich; Eva K Wirth; Jens Peter von Kries; Josef Köhrle; Kostja Renko; Martin Neuenschwander; Niklas Wiese; Rajas Sane; Sabrina Kleissle; Yiming Zhang

Mar 13, 2026